{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:58:12Z","timestamp":1790449092260,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10384-026-01364-x","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:43:05Z","timestamp":1776847385000},"page":"1174-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Branch retinal vein occlusion in Leber hereditary optic neuropathy with onset at age 50 years or older: frequency and clinical characteristics"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-8258","authenticated-orcid":false,"given":"Yasuyuki","family":"Takai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Yamagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Wakakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies: disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81\u2013114.","journal-title":"Prog Retin Eye Res"},{"key":"1364_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/ceo.13326","volume":"46","author":"N Balducci","year":"2018","unstructured":"Balducci N, Cascavilla ML, Ciardella A, La Morgia C, Triolo G, Parisi V, et al. Peripapillary vessel density changes in Leber\u2019s hereditary optic neuropathy: a new biomarker. Clin Exp Ophthalmol. 2018;46:1055\u201362.","journal-title":"Clin Exp Ophthalmol"},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1159\/000518185","volume":"64","author":"J Yu","year":"2021","unstructured":"Yu J, Xu H, Huang Y, Gu R, Zong Y, Zhu H, et al. Changes in retinal perfusion in Leber\u2019s hereditary optic neuropathy: an optical coherence tomography angiography study. Ophthalmic Res. 2021;64:863\u201370.","journal-title":"Ophthalmic Res"},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1042\/CS20110199","volume":"122","author":"P Minuz","year":"2012","unstructured":"Minuz P, Fava C, Vattemi G, Arcaro G, Riccadonna M, Tonin P, et al. Endothelial dysfunction and increased oxidative stress in mitochondrial diseases. Clin Sci (Lond). 2012;122:289\u201397.","journal-title":"Clin Sci (Lond)"},{"key":"1364_CR5","first-page":"380","volume":"19","author":"C Garnavou-Xirou","year":"2024","unstructured":"Garnavou-Xirou C, Bontzos G, Smoustopoulos G, Velissaris S, Papadopoulos A, Georgopoulos E, et al. Systemic risk factors in branch retinal vein occlusion: a comprehensive review. Maedica (Bucur). 2024;19:380\u20137.","journal-title":"Maedica (Bucur)"},{"key":"1364_CR6","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1167\/iovs.17-21990","volume":"58","author":"N Vestergaard","year":"2017","unstructured":"Vestergaard N, Rosenberg T, Torp-Pedersen C, Vorum H, Andersen N, Leergaard TB. Increased mortality and comorbidity associated with Leber\u2019s hereditary optic neuropathy: a nationwide cohort study. Invest Ophthalmol Vis Sci. 2017;58:4586\u201392.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1364_CR7","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1167\/iovs.09-4453","volume":"51","author":"M Yasuda","year":"2010","unstructured":"Yasuda M, Kiyohara Y, Arakawa S, Hata Y, Yonemoto K, Doi Y, et al. Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci. 2010;51:3205\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICU.0000000000000410","volume":"28","author":"N Jurkute","year":"2017","unstructured":"Jurkute N, Yu-Wai-Man P. Leber hereditary optic neuropathy: bridging the translational gap. Curr Opin Ophthalmol. 2017;28:403\u20139.","journal-title":"Curr Opin Ophthalmol"},{"key":"1364_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1084604","volume":"13","author":"K Qu","year":"2022","unstructured":"Qu K, Yan F, Qin X, Li H, Zhao W, Ai X, et al. Mitochondrial dysfunction in vascular endothelial cells and its role in atherosclerosis. Front Physiol. 2022;13:1084604.","journal-title":"Front Physiol"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.ajpath.2025.05.006","volume":"195","author":"F Takano","year":"2025","unstructured":"Takano F, Kitamura M, Ueda K, Nakamura M. Nitric oxide may adversely affect the metabolism and viability of retinal organoids derived from patients with Leber hereditary optic neuropathy. Am J Pathol. 2025;195:1693\u2013706.","journal-title":"Am J Pathol"},{"key":"1364_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4936924","volume":"2017","author":"J Li","year":"2017","unstructured":"Li J, Paulus YM, Shuai Y, Fang W, Liu Q, Yuan S. New developments in the classification, pathogenesis, risk factors, natural history, and treatment of branch retinal vein occlusion. J Ophthalmol. 2017;2017:4936924.","journal-title":"J Ophthalmol"},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/archopht.1984.01040030783017","volume":"102","author":"E Nikoskelainen","year":"1984","unstructured":"Nikoskelainen E, Hoyt WF, Nummelin K, Schatz H. Fundus findings in Leber\u2019s hereditary optic neuroretinopathy. III. Fluorescein angiographic studies. Arch Ophthalmol. 1984;102:981\u20139.","journal-title":"Arch Ophthalmol"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/01658107.2024.2389957","volume":"49","author":"Y Takai","year":"2025","unstructured":"Takai Y, Yamagami A, Iwasa M, Inoue K, Yasumoto R, Ishikawa H, et al. Leber\u2019s hereditary optic neuropathy with retinal hemorrhage. Neuroophthalmology. 2025;49:127\u201331.","journal-title":"Neuroophthalmology"},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3109\/13816810.2010.531880","volume":"32","author":"YT Hsieh","year":"2011","unstructured":"Hsieh YT, Yang MT, Peng YJ, Hsu WC. Central retinal vein occlusion as the initial manifestation of LHON\/MELAS overlap syndrome with mitochondrial DNA G13513A mutation: case report and literature review. Ophthalmic Genet. 2011;32:31\u20138.","journal-title":"Ophthalmic Genet"},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/09286586.2015.1082604","volume":"23","author":"V Koh","year":"2016","unstructured":"Koh V, Cheung CY, Li X, Tian D, Wang JJ, Mitchell P, et al. Retinal vein occlusion in a multi-ethnic Asian population: the Singapore epidemiology of eye disease study. Ophthalmic Epidemiol. 2016;23:6\u201313.","journal-title":"Ophthalmic Epidemiol"},{"key":"1364_CR16","first-page":"133","volume":"98","author":"R Klein","year":"2000","unstructured":"Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000;98:133\u201341.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132:2317\u201326.","journal-title":"Brain"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01364-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01364-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:01:53Z","timestamp":1790445713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01364-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01364-x","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Takai, Lecture fee (Senju); A. Yamagami, Payment or honoraria for speaking engagements (Teijin, Chugai, Santen, Amgen, Senju, Viatris, Novartis); K. Inoue, Grants or contracts (Santen, Teijin, Ono, Senju, GSK, A2 Healthcare, Seed), Lecture fee (Senju, Kowa, Santen, Chugai, Otsuka, Rohto Nitten); H. Ishikawa, None; M. Wakakura, Patents planned, issued or pending (TOKAI Optical).","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}